P2RY12 and myocardial infarction: The neutral effect of P2Y12 inhibitor monotherapy on total and vascular mortality compared to aspirin monotherapy, with precise risk estimates, suggests that the beneficial treatment effect observed in MI does not translate into significant improvement in clinical outcomes.